Publication | Open Access
An Open-label, Phase II Study of the Safety and Tolerability of Pirfenidone in Patients with Scleroderma-associated Interstitial Lung Disease: the LOTUSS Trial
262
Citations
18
References
2016
Year
ClinicalTrials.gov; www.clinicaltrials.gov NCT01933334.
| Year | Citations | |
|---|---|---|
Page 1
Page 1